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Joint replacementRecently, nanometre-sized UHMWPE particles generated from hip and knee replacements have been
identiﬁed in vitro and in vivo. UHMWPE particles in the 0.1–1.0 lm size range have been shown to be
more biologically active than larger particles, provoking an inﬂammatory response implicated in late
aseptic loosening of total joint replacements. The biological activity of nanometre-sized particles has
not previously been studied. The biological response to clinically-relevant UHMWPE wear particles
including nanometre-sized and micrometre-sized, along with polystyrene particles (FluoSpheres
20 nm, 60 nm, 200 nm and 1.0 lm), and nanometre-sized model polyethylene particles (Ceridust
3615), was determined in terms of osteolytic cytokine release from primary human peripheral blood
mononuclear cells (PBMNCs). Nanometre-sized UHMWPE wear particles, nanometre-sized Ceridust
3615 and 20 nm FluoSpheres had no signiﬁcant effect on TNF-a, IL-1b, IL-6 and IL-8 release from
PBMNCs at a concentration of 100 lm3 particles per cell after 12 and 24 h. The micrometre-size
UHMWPE wear particles (0.1–1.0 lm) and 60 nm, 200 nm and 1.0 lm FluoSpheres caused signiﬁcantly
elevated osteolytic cytokine release from PBMNCs. These results indicated that particles below circa
50 nm fail to activate PBMNCs and that particle size, composition and morphology played a crucial role
in cytokine release by particle stimulated macrophages.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
UHMWPE wear particles have been implicated in late aseptic
loosening of conventional total hip replacements (THR) [1,2]. As
these particles are generated and released into the tissue sur-
rounding the implant, macrophages attempt to digest the foreign
material. Polyethylene is, however, inert and it cannot be broken
down. The macrophages become activated and release
pro-inﬂammatory mediators such as tumour necrosis factor-a
(TNF-a) and interleukins, IL-1b, IL-6 and IL-8. In a complex
sequence of events osteoclasts are activated to resorb the bone at
the bone-implant interface and an imbalance in normal bone
metabolism results in painful loosening of the prosthesis [3–5].
Alternative bearing materials such as metals and ceramics with
lower wear rates were introduced to solve the problems associated
with particle-induced osteolysis [6]. However, the high failure rate
of metal on metal bearings as well as serious adverse tissue reac-
tions [7–14] and the high cost of ceramic bearings have led to
UHMWPE bearings remaining dominant in THR. Currently, themost common bearing surface material in THR is highly cross-
linked UHMWPE, which has been successfully used in the clinic
for more than a decade.
The osteolytic potential of the UHMWPE wear particles is
dependent on particle size and volume. It has been reported that
UHMWPE particles in the size range of 0.1–1.0 lm are more bio-
logically active than larger particles in terms of osteolytic cytokine
release [15,16]. Recently, nanometre-sized UHMWPE particles
have been identiﬁed both in in vitro wear test lubricants and in tis-
sues retrieved at revision surgery [17–20]. Most importantly,
highly crosslinked UHMWPEs have been shown to produce large
numbers of nanometre-sized wear particles and generate higher
volumes of nanometre-sized wear particles compared to conven-
tional non-crosslinked UHMWPE [21,22]. Previous studies that
have assessed the biological activity of UHMWPE particles
in vitro have not considered particles in the nanometre-size range
[15,16,23,24]. Therefore, it is essential to determine the relative
contribution of particles less than 100 nm in size to the inﬂamma-
tory process of osteolysis in total hip replacements.
The aims of this study were to determine the capacity of
nanometre-sized polymer particles to activate human peripheral
blood derived mononuclear phagocytes (PBMNC) to produce oste-
olytic cytokines in vitro. Particles investigated included commer-
cially available model particles (FluoSpheres and Ceridust 3615)
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multidirectional articulation. A large volume of endotoxin-free
clinically-relevant nanometre-sized UHMWPE particles was gener-
ated using RPMI 1640 medium lubricant in multi-directional
pin-on-plate wear tests. Particles were cultured with PBMNCs iso-
lated from healthy volunteers and cell viability and cytokine
release were measured.2. Materials and methods
2.1. Preparation of polymer particles
2.1.1. Generation of micrometre-sized and nanometre-sized UHMWPE
wear particles
UHMWPE wear particles were generated from GUR 1020 GVF
UHMWPE pins (gamma irradiated at a dose of 2.5–4 MRad in a vac-
uum; bar stock supplied by DePuy International Ltd., UK) against
medical grade high carbon (>0.2%, w/w) cobalt chromium alloy
plates (School of Mechanical Engineering, University of Leeds, UK)
with a surface roughness (Ra) of 0.07–0.08 lm using a six station
multi-directional pin-on-plate wear simulator. RPMI 1640 medium
wasused as the lubricant (Bio-Whittaker, Lonza, Belgium) according
to establishedmethods detailed in our previous study [25]. Post-test
lubricants containing UHMWPE wear particles were collected.
Micrometre-sized UHMWPE wear particles (Micro-wear-0.1–
1.0 lm)were isolated from the sonicatedwear test lubricants by ﬁl-
tration through 10 lm, 1 lm, 0.6 lm and ﬁnally onto a preweighed
0.1 lmpolycarbonatemembraneﬁlter (Whatman, Kent, UK). Larger
micrometre-sized UHMWPE wear particles (Micro-wear-1.0–
10 lm)were isolated fromwear test lubricants by ﬁltration through
a 10 lmﬁlter and then onto to a preweighed 1 lmﬁlter. The 0.1 lm
and 1 lm ﬁlters containing particles were dried under infrared
lamps for 4 h and weighed 5 times using a microbalance with an
accuracy of 1  106 g in an environmentally controlled room. The
mass of micrometre-sized particles on the 0.1 lm ﬁlter and the
1 lm ﬁlter was calculated. A ﬁlter sequence of 10 lm, 1 lm,
0.1 lm, 0.1 lm and 0.015 lm pore sizes was used to isolate
nanometre-sized UHMWPE wear particles (<100 nm) on the
0.015 lm ﬁlters. The mass of nanometre-sized UHMWPE wear par-
ticles on the 0.015 lm ﬁlter was determined as above.
2.1.2. Commercially available polystyrene FluoSpheres
FluoSpheres (FS, Invitrogen Life Technologies Ltd., Paisley, UK)
were purchased in 20 nm, 40 nm, 200 nm and 1.0 lm sizes and
stored at 4 C with protection from light.
2.1.3. Commercially available polyethylene resin, Ceridust 3615
Ceridust 3615-a low molecular weight polyethylene resin
(Hoechst, Germany) was dispersed in a solution consisting of
RPMI 1640 medium plus 0.08% (v/v) 7X-PF detergent (ICN
Biomedicals Inc., USA). After sonication for 40 min, the suspension
was ﬁltered through a ﬁlter sequence of 10 lm, 1 lm, 0.1 lm,
0.1 lm and ﬁnally onto a preweighed 0.015 lm pore sizes. The
mass of particles collected on the 0.015 lm ﬁlter was determined.
2.2. Characterisation of polymer particles
The polymer particles were characterised using images cap-
tured by high resolution ﬁeld emission gun-scanning electron
microscopy (FEG-SEM, LEO Electron Microscopy Ltd., Cambridge,
UK). Each type of fractionated polymer particle was suspended in
RPMI 1640 medium with 20 mM HEPES (N-(2-hydroxyethyl) pipe
razine-N0-(2-ethanulfonic acid) (Bio-Whittaker, Lonza, Belgium)
and 100 U ml1 penicillin/streptomycin (Bio-Whittaker, Lonza,
Belgium). A volume of 24 ll of FluoSpheres, 100 ll of fractionatednanometre-sized Ceridust and 100 ll of each of the UHMWPE wear
particle suspensions was resuspended in 70% (v/v) ethanol (VWR
International Poole, UK) and ﬁltered through a 0.015 lm ﬁlter.
Sections of each ﬁlter were mounted on aluminium stubs using
double sided carbon pads and coated with 3.0 nm platinum/palla-
dium using a sputter coater (Agar Scientiﬁc Ltd., UK). A minimum
of 100 particles were analysed for each sample using a wide range
of magniﬁcations (1000–200,000). The particle distributions
were determined using Image Pro Plus software (Media
Cybernetics, Maryland, USA) by measuring the size (length) and
area of particles on the ﬁlters.
2.3. Endotoxin testing of polymer particles using the LAL assay
The Pyrochrome Limulus Amebocyte Lysate (LAL) kinetic-QCL
endotoxin assay (Associates of Cape Cod Incorporated, USA) was
used to determine the presence of endotoxin in all particle stocks.
Particle samples were diluted 1:1000 using LAL reagent water. A
series of four endotoxin standards (5 EU ml1, 0.5 EU ml1,
0.05 EU ml1 and 0.005 EU ml1) were generated using Control
Standard Endotoxin (CSE, 10 ng/vial, which was reconstituted to
give a concentration of 100 EU ml1). A 96-well plate loaded with
1:1 ratio of samples and pyrochrome reconstitution reagent was
placed in an absorbance micro plate reader (Bio-Tek, USA), shaken
for 10 s and the assay was carried out at 37 C for 1.5 h. A measure-
ment ﬁlter of 405 nm was used. The test system was set up using
KC4 software. The concentration of endotoxin present in the parti-
cle suspensions was calculated from reaction time using a standard
curve, where the rate of colour change was directly proportional to
the amount of endotoxin present.
2.4. Culture of human peripheral blood mononuclear cells (PBMNCs)
with polymer particles
Heparinised blood (30 ml) was obtained by venepuncture of 9
healthy volunteer donors (aged 20–55 years, 6 females and 3
males). All blood was collected in accordance with the Faculty of
Biological Sciences Ethics Committee approval (R1307 and BIOSCI
10-018) and informed consent was obtained from the donor prior
to venepuncture. The mononuclear cell fraction (PBMNC) was iso-
lated by density gradient centrifugation on Lymphoprep
(Axis-Shield PoC AS, Oslo, Norway). The PBMNCs were collected
and suspended in a known volume of cell culture medium (RPMI
1640 medium with 10% (v/v) foetal bovine serum (Bio-Whittaker,
Lonza, Belgium), 2 mM L-glutamine (Bio-Whittaker, Lonza,
Belgium) and 100 U ml1 penicillin/streptomycin (Bio-Whittaker,
Lonza, Belgium). The number of phagocytic cells was determined
using a latex bead ingestion assay [26].
Particles were cultured with PBMNCs using an agarose gel tech-
nique as described previously [27]. Cells were seeded at
1.125  105 cells per well in 48 well plates containing particles in
low melting point agarose (Invitrogen Life Technologies Ltd.,
Paisley, UK) at a concentration (particle volume (lm3): cell number
ratio) of 100:1 (n = 4). A volume of 1.125  107 lm3 particles was
required for each well to give a concentration of (particle volume
(lm3): cell number ratio) of 100:1. The density of polyethylenewear
particleswas assumed to be1  106 lg lm3. So the requiredmass
of wear particles per well was calculated by the equation below:
Weight of particles ¼ Volume of particles Density
¼ 1:125 107 lm3  1 106 lg lm3
¼ 11:25 lg
Cells cultured without particles (n = 4) were used as a negative
control and cells treated with 200 ng ml1 of lipopolysaccharides
(LPS) (n = 4) (Sigma–Aldrich, St. Louis, MO, USA) were used as a
Fig. 1. FEG-SEM images of FluoSpheres (FS), Ceridust 3615 and UHMWPE wear particles: (a) 20 nm FS, magniﬁcation of 90,000; (b) 40 nm FS, magniﬁcation of 90,000; (c)
nanometre-sized Ceridust 3615 particles, magniﬁcation of 200,000; (d) nanometre-sized UHMWPE wear particles, magniﬁcation of 200,000; (e) 200 nm FS,
magniﬁcation of 90,000; (f) 1 lm FS, magniﬁcation of 60,000; (g) UHMWPE wear particles (Micro-wear-0.1–1.0 lm), magniﬁcation of 90,000); (h) UHMWPE wear
particles (Micro-wear-1.0–10 lm), magniﬁcation of 65,000.
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atmosphere of 5% (v/v) CO2 in air and 100% humidity at 37 C for
12 and 24 h. Culture supernatants were harvested and stored at
20 C in 96 well polypropylene plates for a maximum of one
month for cytokine measurement. Cell viability was determined
by ATP Lite assay (PerkinElmer, USA). TNF-a and interleukin
(IL-1b, IL-6 and IL-8) release was measured by enzyme linked
immunosorbent assay (ELISA, IDS, Michigan, USA) at 12 and 24 h.
In order to visualise the cellular uptake of UHMWPE wear par-
ticles within agarose gels using confocal laser scanning micro-
scopy, UHMWPE wear particles were labelled with sodium
ﬂuorescein, according to methods described in a previous study
[28]. The nanometre-sized (<100 nm) and 0.1–1.0 micrometr
e-sized UHMWPE wear particles were stained using ﬂuorescein
solution (1 mg ml1; Fisher Scientiﬁc Ltd., UK) at a concentration
of 1:10 at 4 C. PBMNCs were cultured in custom made wells on
microscope slides (Thermo Scientiﬁc, Menzel-Glaser, UK) with
green ﬂuorescently labelled nanometre-sized (<100 nm) and 0.1–
1.0 micrometre-sized UHMWPE wear particles at a concentration
of 100 lm3 per cell for 48 h using the agarose gel method. Thenuclei of cells were stained with Hoechst 33342 (Life
Technologies, UK) at a concentration of 1.0 lM. Cells were then
imaged using a confocal laser scanning upright Zeiss LSM510
microscope (Carl Zeiss Ltd., UK).2.5. Statistical analysis
Data are shown as mean ± 95% conﬁdence interval and were
analysed by a one-way ANOVA. Differences between the treatment
groups and the negative control were determined by calculating
the minimum signiﬁcant difference (MSD) (p < 0.05) by the
Tukey-method.3. Results
3.1. Characterisation of polymer particles
The morphologies of nanometre-sized polymer particles are
shown in Fig. 1a–d. The 20 nm and 40 nm FS on the 0.015 lm ﬁlter
Fig. 2. The percentage (a) number and (b) area distributions of 20 nm and 60 nm FS, compared to nanometre-sized Ceridust 3615 (Nano-Ceridust) and nanometre-sized
UHMWPE wear particles (Nano-wear); The percentage (c) number and (d) area distributions of 200 nm and 1 lm FS, compared to micrometre-sized UHMWPE wear (Micro-
wear-0.1–1.0 lm) and micrometre-sized UHMWPE wear particles (Micro-wear-1.0–10 lm).
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granular nanometre-sized Ceridust 3615 particles were observed
clearly at a magniﬁcation of 200,000 (Fig. 1c). Agglomerated
nanometre-sized granular UHMWPE wear particles with a size
range of less than 50 nm were abundant on the 0.015 lm ﬁlter
(Fig. 1d).
The morphologies of micrometre-sized polymer particles are
shown in Fig. 1e–h. The 200 nm FS and 1 lm FS on the 0.015 lm
ﬁlters had regular round morphologies (Fig. 1e and f). The
UHMWPE wear particles (Micro-wear-0.1–1.0 lm) isolated using
a ﬁlter sequence of 10 lm, 1 lm, 0.6 lm and 0.1 lm pore sizes
had agglomerated ﬂake-like morphologies (Fig. 1g). The morpholo-
gies of UHMWPE wear particles (Micro-wear-1.0–10 lm) isolated
using a ﬁlter sequence of 10 lm and 1 lm pore sizes with an
expected size range of 1.0–10 lm are shown in Fig. 1h. Large
ﬂake-like particles were observed, while a large number of
nanometre-sized UHMWPE particles were also present on the ﬁlter
(Fig. 1h).
The number and area distributions of nanometre-sized polymer
particles as a function of size are shown in Fig. 2a and b. The
nanometre-sized UHMWPE wear particles had a mode number in
the 30–39 nm size range (Fig. 2a). For nanometre-sized Ceridust
3615, the mode of the number of particles was in the 20–29 nm
size range (Fig. 2a). The 20 nm and 40 nm FS showed narrower
number and area distributions compared to those of fractionated
nanosized UHMWPE wear particles and Ceridust particles
(Fig. 2a and b). The mode of the number of 20 nm FS was in the size
range of 20–29 nm (Fig. 2a). The mode of the number of 40 nm FS
was in the size range of 50–59 nm (Fig. 2a). The majority of 40 nmFS particles were in the size range of >50 nm, while particles with a
size range of <50 nm occupied the majority of the number of all the
other three types of particles including 20 nm FS, nanometre-sized
UHMWPE wear particles and nanometre-sized Ceridust 3615 par-
ticles. The 40 nm FS are therefore referred as 60 nm FS for the
remainder of this paper.
The number and area distributions of micrometre-sized poly-
mer particles as a function of size are shown in Fig. 2c and d. The
200 nm FS and 1 lm FS showed narrower distributions compared
to fractionated UHMWPE wear particles. All of the 200 nm FS were
within a size range of 0.2–0.29 lm and all of the 1.0 lm FS were
within a size range of 1.0–2.0 lm. The mode of both the number
and the area distributions of micrometre-sized UHMWPE wear
particles (Micro-wear-0.1–1.0 lm) were in the size range of 0.1–
0.19 lm. The micrometre-sized UHMWPE particles with an
expected size range of 1.0–10 lm (Micro-wear-1.0–10 lm) had a
mode number in the size range of 30–39 nm (Fig. 2c). Particles
with a size range of 1.0–9.9 lm represented only 1.6% of the num-
ber of particles (Fig. 2c), however, these particles accounted for
91.8% of the area of particles (Fig. 2d).3.2. Endotoxin levels of polymer particles
All the particle stocks including each size of FS, fractionated
Ceridust 3615 particles and UHMWPE wear particles showed
minimum endotoxin levels of <0.5 Endotoxin Units (EU) ml1,
which were below the accepted value of <5 Endotoxin Units
(EU kg1) according to the speciﬁcation of the endotoxin tolerance
Fig. 3. TNF-a released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 5 donors after stimulation with 100 lm3 of 20 nm, 60 nm, 200 nm and 1.0 lm FS per cells
over 12 h and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3; (d) Donor 4 and (e) Donor 5. Positive control: 200 ng ml1 of LPS; Negative control: Cells only. *Indicates a
statistically signiﬁcant elevation of cytokines compared to the cells only control (ANOVA, p < 0.05).
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(FDA Regulatory Affairs, 1985).3.3. Cellular responses to polymer particles in terms of osteolytic
cytokine release
3.3.1. Cell viability
Results obtained from the ATP Lite cell viability assay indicated
that there was no adverse effect on cell viability within any of the
treatment groups compared to the negative control (cells only),
data not shown.3.3.2. Cellular responses to FluoSphere particles
PBMNCs isolated from ﬁve donors were cultured with 100 lm3
per cell of the 20 nm, 60 nm, 200 nm and 1.0 lm sized FluoSpheres(FS) for 12 and 24 h. The results for TNF-a, IL-1b, IL-6 and IL-8
release by the cells isolated from ﬁve donors are shown in
Figs. 3–6, respectively. A summary of donors that were stimulated
to release signiﬁcant elevations of cytokines compared to cells only
control is shown in Table 1.
3.3.2.1. TNF-a release from particle-stimulated PBMNCs. The 1.0 lm
sized FS stimulated cells from 4/5 donors to produce signiﬁcantly
higher levels of TNF-a after 12 and 24 h compared to the cells only
negative control. The 200 nm FS caused signiﬁcantly elevated pro-
duction of TNF-a released by cells from 3/5 donors at the 12 h time
point and cells from 2/5 donors at the 24 h time point. The 60 nm
FS caused signiﬁcant elevation of TNF-a release by cells from 4/5
donors at 12 h and cells from 2/5 donors at 24 h. The 20 nm FS only
stimulated cells from 1/5 donor to produce signiﬁcantly higher
levels of TNF-a at the 24 h time point compared to the cells only
control.
Fig. 4. IL-1b released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 5 donors after stimulation with 100 lm3 of 20 nm, 60 nm, 200 nm and 1.0 lm FS per cells over
12 h and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3; (d) Donor 4 and (e) Donor 5. Positive control: 200 ng ml1 of LPS; Negative control: Cells only. *Indicates a statistically
signiﬁcant elevation of cytokines compared to the cells only control (ANOVA, p < 0.05).
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sized FS stimulated signiﬁcantly higher amounts of IL-1b released
by cells from 3/5 donors at the 12 h time point and cells from
4/5 donors at the 24 h time point, compared to the cells only con-
trol. The 200 nm FS caused signiﬁcant elevation of IL-1b production
by cells from 2/5 donors at 12 h and 1/5 donor at 24 h. The 60 nm
FS stimulated cells from 1/5 donor to release higher amounts of
IL-1b at the 12 h time point, compared to the control. For the
20 nm FS, there was no signiﬁcant production of IL-1b by cells from
any of the ﬁve donors at any time point.
3.3.2.3. IL-6 release from particle-stimulated PBMNCs. For 1.0 lm
sized FS, there was signiﬁcant production of IL-6 by cells from all
donors after 12 h and cells from 3/5 donors after 24 h. The
200 nm FS caused signiﬁcant elevation of IL-6 release by cells from
4/5 donors at 12 h and 1/5 donor at 24 h time point. The 60 nm FScaused higher amounts of IL-6 released by cells from all donors at
the 12 h time point, and 4/5 donors at the 24 h time point, com-
pared to the control. The 20 nm FS only stimulated signiﬁcant ele-
vation of IL-6 released by cells from 2/5 donors at 12 h time point.
The 20 nm FS did not cause any signiﬁcant production of IL-6 by
cells from any donors after 24 h.3.3.2.4. IL-8 release from particle-stimulated PBMNCs. The 1.0 lm
sized FS caused signiﬁcant elevation of IL-8 production by cells
from all donors at both of 12 h and 24 h time points. Similar trends
were observed for cells treated with 200 nm FS and 60 nm FS
which caused signiﬁcant higher amounts of IL-8 released by cells
from all donors after 12 h and 24 h, compared to the control. For
the 20 nm FS, signiﬁcant production of IL-8 was only observed in
cells from 3/5 donors at 12 h and cells from 1/5 donor at 24 h.
Fig. 5. IL-6 released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 5 donors after stimulation with 100 lm3 of 20 nm, 60 nm, 200 nm and 1.0 lm FS per cells over
12 h and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3; (d) Donor 4 and (e) Donor 5. Positive control: 200 ng ml1 of LPS; Negative control: Cells only. *Indicates a statistically
signiﬁcant elevation of cytokines compared to the cells only control (ANOVA, p < 0.05).
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nanometre-sized polymer particles and micrometre-sized polymer
particles
PBMNCs isolated from three donors were cultured with
100 lm3 per cell of nanometre-sized polymer particles and
micrometre-sized polymer particles for 12 and 24 h. The results
for TNF-a, IL-1b, IL-6 and IL-8 release by the cells isolated from
three donors are shown in Figs. 7–10, respectively. A summary of
donors that were stimulated to release signiﬁcant elevations of
cytokines compared to cells only control is shown in Table 2.3.3.3.1. TNF-a release from particle-stimulated PBMNCs. The 60 nm
FS caused signiﬁcantly higher levels of TNF-a release from all three
donors after incubation for 12 h and 24 h compared to the cells
only negative control. Micrometre-sized UHMWPE wear particles
(Micro-wear-0.1–1.0 lm) stimulated signiﬁcant elevation ofTNF-a release by cells isolated from 3/3 donors at the 12 h time
point and cells from 1/3 donors at the 24 h time point.
Signiﬁcantly elevated levels of TNF-a were released by cells from
1/3 donors in response to the micrometre-sized UHMWPE wear
particles (Micro-wear-1.0–10 lm) at the 24 h time point. The
nanometre-sized UHMWPE wear particles and nanometre-sized
Ceridust 3615 did not stimulate cells from any of the three donors
to produce elevated levels of TNF-a at any time point, compared to
the cells only negative control.3.3.3.2. IL-1b release from particle-stimulated PBMNCs. The 60 nm FS
caused signiﬁcantly elevated levels of IL-1b release by cells from all
three donors at both time points tested (12 h and 24 h). Cells from
3/3 donors treated with micrometre-sized UHMWPE wear parti-
cles (Micro-wear-0.1–1.0 lm) secreted signiﬁcantly elevated con-
centrations of IL-1b after 12 h, but no signiﬁcantly increased
Fig. 6. IL-8 released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 5 donors after stimulation with 100 lm3 of 20 nm, 60 nm, 200 nm and 1.0 lm FS per cells over
12 h and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3; (d) Donor 4 and (e) Donor 5. Positive control: 200 ng ml1 of LPS; Negative control: Cells only. *Indicates a statistically
signiﬁcant elevation of cytokines compared to the cells only control (ANOVA, p < 0.05).
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UHMWPE wear particles, nanometre-sized Ceridust 3615 and
micrometre-sized UHMWPE wear particles (Micro-wear-1.0–
10 lm) failed to stimulate signiﬁcantly elevated levels of IL-1b
release from cells from any of the three donors at either time point
compared to the negative control.3.3.3.3. IL-6 release from particle-stimulated PBMNCs. The 60 nm FS
stimulated signiﬁcantly higher amounts of IL-6 release by cells
from 3/3 donors at both time points tested (12 h and 24 h), com-
pared to the cells only control. The micrometre-sized UHMWPE
wear particles (Micro-wear-0.1–1.0 lm) caused signiﬁcantly ele-
vated IL-6 release by cells from 1/3 donor after 12 h and 24 h.
Neither micrometre-sized UHMWPE wear particles
(Micro-wear-1.0–10 lm), nanometre-sized UHMWPE wear parti-
cles or nanometre-sized Ceridust 3615 caused any signiﬁcantelevation of IL-6 at 12 h or 24 h, compared to the cells only nega-
tive control.3.3.3.4. IL-8 release from particle-stimulated PBMNCs. There was
abundant IL-8 secreted from cells without particle stimulation
(negative control ranges from 0.96–4.57 ng ml1). The 60 nm FS
stimulated signiﬁcantly higher levels of IL-8 release by cells from
2/3 donors at 12 h and 3/3 donors at 24 h, compared to the nega-
tive control. The micrometre-sized UHMWPE wear particles
(Micro-wear-0.1–1.0 lm) provoked signiﬁcantly high amounts of
IL-8 release at the 12 time point (3/3 donors) and at the 24 time
point (2/3 donors). The micrometre-sized UHMWPE wear particles
(Micro-wear-1.0–10 lm) stimulated a signiﬁcantly high level of
IL-8 release by cells from 1/3 donors at the 24 h time point. No sig-
niﬁcant increase in the production of IL-8 by cells from all three
donors was observed for nanometre-sized UHMWPEwear particles
and nanometre-sized Ceridust 3615 at both time points.
Table 1
Cytokine release from 5 donors when stimulated with 20 nm, 60 nm, 200 nm and 1.0 lm FS particles at a concentration of 100 lm3 particles per cell over 12 and 24 h.
Particles Cytokine release
12 h 24 h
TNF-a IL-1b IL-6 IL-8 TNF-a IL-1b IL-6 IL-8
20 nm FS N N D1
D3
D2
D4
D5
D1 N N D5
60 nm FS D2
D3
D4
D5
D2 D1
D2
D3
D4
D5
D1
D2
D3
D4
D5
D2
D3
N D2
D3
D4
D5
D1
D2
D3
D4
D5
200 nm FS D2
D4
D5
D2
D4
D1
D2
D3
D5
D1
D2
D3
D4
D5
D2
D3
D5 D2 D1
D2
D3
D4
D5
1.0 lm FS D2
D3
D4
D5
D2
D4
D5
D1
D2
D3
D4
D5
D1
D2
D3
D4
D5
D2
D3
D4
D5
D2
D3
D4
D5
D2
D4
D5
D1
D2
D3
D4
D5
Notes: The symbols represent whether there was signiﬁcant cytokine release. Where N = no signiﬁcant cytokine release and D1, D2, D3, D4, D5 depict signiﬁcant cytokine
release: D1 = Donor 1; D2 = Donor 2; D3 = Donor 3; D4 = Donor 4; D5 = Donor 5.
Fig. 7. TNF-a released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 3 donors after stimulation with nanometre-sized and micrometre-sized polymer particles at
a dose of 100 lm3 particles per cell over 12 and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3. *Indicates a statistically signiﬁcant elevation of cytokines compared to the cells
only negative control (ANOVA, p < 0.05).
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Fig. 8. IL-1b released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 3 donors after stimulation with nanometre-sized and micrometre-sized polymer particles at a
dose of 100 lm3 particles per cell over 12 and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3. *Indicates a statistically signiﬁcant elevation of cytokines compared to the cells only
negative control (ANOVA, p < 0.05).
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wear particles uptake by PBMNCs
Confocal images (Fig. 11) showed cells with blue nuclei and
internalised green ﬂuorescently labelled nanometre-sized and
micrometre-sized UHMWPE wear particles. The confocal images
were taken in the midsection of the cells to ensure that the ﬂuores-
cence signal observed was from particles that had been endocy-
tosed by PBMNCs. For cells plus nanometre-sized particles, the
bright punctate ﬂuorescence particles were observed as spots
accumulated in the perinuclear region, which indicated the
agglomerated nanometre-sized UHMWPE wear particles had been
engulfed by cells (Fig. 11a). The particles presented as black dots
within cells under bright ﬁeld illumination, as shown by the red
arrows. The green spots indicated the localisation of
micrometre-sized UHMWPE wear particles within the cells, which
were also localised around the periphery of the nuclei (Fig. 11b).4. Discussion
It has been shown that nanometre-sized metal particles gener-
ated by metal-on-metal prostheses have the potential to play a role
in adverse tissue reactions such as tissue necrosis and the develop-
ment of pseudotumors [11,29,30]. Compared to metal particles,
UHMWPE is a chemically inert material and phagocytic cells are
not able to degrade the particles once they have been internalised,
in spite of the low pH of the intracellular compartment. Even
though nanometre-sized UHMWPE wear particles occupy arelatively small percentage of the total wear volume generated
by conventional THR, they are produced in large numbers. Due to
their small size, numerous nanometre-sized UHMWPE wear parti-
cles may be disseminated throughout the body and UHMWPEwear
particles have previously been found in patient lymph nodes,
spleen and liver [31–33]. There are no published reports on the
biological response to nanometre-sized UHMWPE wear particles
and it is unclear whether nanometre-sized UHMWPE may con-
tribute to osteolysis in THR. This may be due to the difﬁculty in
obtaining sufﬁcient amounts of clinically relevant nanometre-
sized UHMWPE wear particles for study.
Recently, Pal et al. [34] reported that nanoscale UHMWPE wear
particles caused an inﬂammatory response in terms of IL-6 and
IL-1b release from dendritic cells (DCs). However, the nanoscale
UHMWPE wear particles used in that study had a size range of
0.05–0.2 lm, which are not strictly nanometre-sized particles (size
range of <0.1 lm). The proportion of particles within a size range of
0.1–0.2 lm which has previously been shown to be the most bio-
logically active [16,24] might mask the cellular response to parti-
cles within the true nanometre-size range. Obviously, the results
from the study by Pal et al. [34] did not convincingly answer the
questions regarding the biological response to nanometre-sized
UHMWPE wear particles. In the present study, the aim was to
investigate only nanometre-sized UHMWPE wear particles i.e.
those smaller than 100 nm, in isolation and to determine their con-
tribution to osteolysis.
In the present study, a large volume of sterile clinically-relevant
nanometre-sized UHMWPE wear particles with a mode size of 30–
40 nm was successfully isolated from lubricants generated in a
Fig. 9. IL-6 released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 3 donors after stimulation with nanometre-sized and micrometre-sized polymer particles at a
dose of 100 lm3 particles per cell over 12 and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3. *Indicates a statistically signiﬁcant elevation of cytokines compared to the cells only
negative control (ANOVA, p < 0.05).
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operated in a non-sterile environment. The nanometre-sized
UHMWPE particles had a granular morphology and tended to
agglomerate, which was consistent with particles isolated from
periprosthetic tissues of patients with failed THR [19,20]. The
majority of nanometre-sized particles isolated in the present study
were less than 50 nm in size, which was similar to particle distri-
butions reported in a study on particle analysis from retrieval tis-
sue from THR patients [20]. The ﬂake like shape of
micrometre-sized UHMWPE particles (Micro-wear-0.1–1.0 lm)
isolated from the wear test lubricants were also similar to particles
isolated from the retrieved tissues of patients at revision hip sur-
gery [35]. This indicated that the six station pin-on-plate simula-
tion was an efﬁcient and reliable way of generating endotoxin
free clinically-relevant UHMWPE wear particles with different size
ranges for use in in vitro biological response studies.
The fractionated micrometre-sized UHMWPE wear particles
(Micro-wear-0.1–1.0 lm) had more than 50% of particles within
a size range of 0.1–1.0 lm and the micrometre-sized UHMWPE
wear particles (Micro-wear-1.0–10 lm) comprised 91.8% of the
area of particles within the size range of 1.0–10 lm. These two
types of particles represented particles within the size range of
0.1–10 lmwhich had previously been reported to be the most bio-
logically active [16,27]. This enabled a direct comparison of levels
of osteolytic cytokine release from cells stimulated by
nanometre-sized and micrometre-sized UHMWPE particles. In
addition to size and volume, other factors such as composition,
surface area, surface texture and morphology of wear debris are
also thought to inﬂuence this macrophage-mediated osteolysisprocess [36,37]. Therefore, the cellular response to model particles
including FluoSpheres (FS) and Ceridust 3615 which had differ-
ent particle composition and morphologies to UHMWPE wear par-
ticles was also investigated in this study.
All size ranges of FluoSphere particles showed similar regular
round morphologies in SEM images, therefore, their cellular
response was mainly determined by size distribution. The cellular
response results indicated that 1 lm FS (mode size 1.0–2.0 lm)
were the most biologically active particles, while 20 nm FS (mode
size 20–30 nm) were the least biologically active, which was con-
sistent with the conclusion from our previous study, which showed
that UHMWPE particles within 0.1–10 lm size range are the most
biologically active [27]. For Fluosphere particles, the 1 lm FS
showed higher biological activity than 200 nm FS, however, the
UHMWPE wear particles did not follow this trend. The 0.1–1.0
micrometre-sized UHMWPE wear particles stimulated signiﬁ-
cantly higher levels of TNF-a, IL-1b and IL-8 release by cells from
3/3 donors and IL-6 by cells from 1/3 donors at 12 h. In addition,
these particles stimulated signiﬁcantly elevated TNF-a and IL-6
release for cells from 1/3 donors, and IL-8 release by cells from
2/3 donors at 24 h. However, the 1.0–10 micrometre-sized
UHMWPE wear particles only stimulated cells isolated from 1/3
donors to produce signiﬁcantly higher levels of TNF-a and IL-8 at
24 h. Previous observations have shown that the proportion of par-
ticles which are within the most biologically active size range (0.1–
1.0 lm) is a critical determinant in the biological activity of the
UHMWPE particles [14,22]. Therefore, the lower biological activity
of the 1.0–10 micrometre-sized UHMWPE wear may be explained
by the fact that the 1.0–10 micrometre-sized UHMWPE wear
Fig. 10. IL-8 released (mean ± 95% conﬁdence intervals, n = 3) by PBMNCs from 3 donors after stimulation with nanometre-sized and micrometre-sized polymer particles at a
dose of 100 lm3 particles per cell over 12 and 24 h: (a) Donor 1; (b) Donor 2; (c) Donor 3. *Indicates a statistically signiﬁcant elevation of cytokines compared to the cells only
negative control. #Indicates a statistically signiﬁcant lower level of cytokines compared to the cells only control (ANOVA, p < 0.05).
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logically active size range (0.1–1.0 lm) compared to the 0.1–1.0
micrometre-sized UHMWPE wear particles.
Neither nanometre-sized Ceridust 3615 with a mode size of
20–30 nm or nanometre-sized UHMWPE wear particles with a
mode size of 30–40 nm caused a signiﬁcant increase in the produc-
tion of osteolytic cytokines by cells from 3/3 donors at any time
point, compared to the cells only control. This was consisted with
the results observed from 20 nm FS which demonstrated the low-
est cellular activation among all size range of FS. All these resultsTable 2
Cytokine release from 3 donors when stimulated with nanometre-sized and micrometre-siz
Particles Cytokine release
12 hours
TNF-a IL-1b IL-6
Nano-wear N N N
Nano-Ceridust N N N
Micro-wear-0.1–1.0 lm D1
D2
D3
D1
D2
D3
D1
Micro-wear-1.0–10 lm N N N
60 nm FS D1
D2
D3
D1
D2
D3
D1
D2
D3
Notes: The symbols represent whether there was signiﬁcant cytokine release. Where N =
D1 = Donor 1; D2 = Donor 2; D3 = Donor 3.indicated that there was a lower size limit for cellular activation
regardless of the composition and morphology of particles.
However, there was difference among the cellular response to a
similar size range of particle with different composition and
shapes. Although the 20 nm FS had a similar distribution (as a
function of size) compared to the nanometre-sized Ceridust, the
20 nm FS had higher biological activity. Compared to
nanometre-sized Ceridust 3615, the 20 nm FS were manufactured
from a different material, polystyrene, they also had a more regular
shape and narrower size distribution, which might play a role ined polymer particles at a concentration of 100 lm3 particles per cell over 12 and 24 h.
24 hours
IL-8 TNF-a IL-1b IL-6 IL-8
N N N N N
N N N N N
D1
D2
D3
D1 N D1 D1
D3
N D3 N N D3
D1
D2
D1
D2
D3
D1
D2
D3
D1
D2
D3
D1
D2
D3
no signiﬁcant cytokine release and D1, D2, D3 depict signiﬁcant cytokine release:
Fig. 11. Visualisation of (a) nanometre-sized UHMWPE wear particles and (b) 0.1–1.0 micrometre-sized UHMWPE wear particles internalised by PBMNCs cultured on agarose
gel. Confocal images of single sections through cells are shown. Blue signals represent nuclei stained with Hoechst 33342 and green signals represent ﬂuorescently labelled
nanometre-sized and micrometre-sized UHMWPE particles. Arrows indicate particle aggregates. Size bar: 5 lm.
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micrometre-size particles, the 200 nm FS and 1.0 lm FS showed
higher biological activity than 0.1–1.0 micrometre-sized and 1.0–
10 micrometre-sized UHMWPE wear particles, which also support
the conclusion that composition and shape of particles might play
an important role in determining the cellular response.
The levels of cytokine released by PBMNCs stimulated by
micrometre-sized UHMWPE wear particles (Micro-wear-0.1–
1.0 lm) were much lower than those measured when cells were
stimulated by 60 nm FS at the same dose. These two types of par-
ticles had different size distributions, different compositions and
shapes. The 0.1–1.0 micrometre-sized UHMWPE wear particles
had high proportions of the number and area of particles within
the critical size (0.1–1.0 lm), but they had a much broader size dis-
tribution of particles compared to the 60 nm FS. The large number
and volume of particles outside of the critical size range might
have a signiﬁcant effect on cytokine release by cells stimulated
with the 0.1–1.0 micrometre-sized UHMWPE wear particles.
Compared to fractionated UHMWPE wear particles, the surface of
the FS was much rounder and smoother in appearance, which
might also have contributed to higher cellular response of 60 nm
FS.
Overall, the results indicated that the size, composition and
morphology of the particles all played an important role in the pro-
cess of macrophage activation and the subsequent cytokine
release.
The data presented also add to the evidence of the heterogene-
ity of human individuals in terms of their biological response to
both model particles and UHMWPE wear particles. The concentra-
tion of each osteolytic cytokine released showed marked variation
between the donors in the present study, which was in agreement
with previous studies [16,24], where up to 15-fold differences in
the concentration of cytokine was produced in response to the
same dose of UHMWPE particles. This variation has been postu-
lated to be due to cytokine promoter gene polymorphisms of dif-
ferent individuals [38]. In addition, in the present study, lower
levels of IL-8 release were observed in cells from 1/3 donors in
response to nanometre-sized UHMWPE wear particles,
nanometre-sized Ceridust and micrometre-sized UHMWPE wear
particles (Micro-wear-1.0–10 lm), which are also postulated to
be due to donor speciﬁc responses.
The concentration of agarose gels used in this study was 0.3%
(w/v) which has been shown to have a peak distribution of pore
diameters of 8 lm (ranging from 2 lm to 13 lm) [39].
Monocytes are approximately 12–20 lm in diameter, therefore,
the 0.3% (w/v) gel was not only able to provide a solid supportfor the particles but also offered an environment for the free migra-
tion of humanmonocytes within the gel. The confocal images show
that both nanometre-sized and micrometre-sized UHMWPE wear
particles were endocytosed by PBMNCs, which provides the evi-
dence that PBMNCs cultured using the agarose gel method were
able to take up nanometre-sized UHMWPE particles. No signiﬁcant
differences were observed in the number of nanometre-sized and
micrometre-sized UHMWPE wear particles taken up by cells,
which indicated that the gel did not play a role in determining
the cellular response to UHMWPE wear particles. Therefore, the
gel-particle-challenge method was feasible to investigate the bio-
logical activity of UHMWPE wear particles. In order to determine
why the engulfed nanometre-sized UHMWPE particles did not
cause an inﬂammatory response, further investigations are being
carried out to determine the relationship between the cellular
uptake mechanism and cellular response to different sizes of
UHMWPE wear particles.5. Conclusions
In this study sterile clinically-relevant nanometre-sized
UHMWPE wear particles which had a size range of <50 nm, were
successfully generated and isolated. The results showed for the
ﬁrst time that nanometre-sized UHMWPE wear particles with a
size range of <50 nm did not stimulate proinﬂammatory cytokine
release including TNF-a, IL-1b, IL-6 and IL-8, from human periph-
eral blood mononuclear cells (PBMNCs). This conclusion has
answered long-term clinical concerns about the biological
response to the large number of nanometre-sized UHMWPE wear
particles which are generated from highly crosslinked UHMWPE
acetabular cups in total hip replacements. In addition, this study
indicated that size, composition and morphology of particles
played an important role in the particle-induced osteolysis process.
Further investigation to determine the cellular uptake mechanism
of clinically-relevant nanometre-sized UHMWPE wear particles
compared to micrometre-sized UHMWPE wear particles is under-
way with the aim of revealing the relationship between the cellular
uptake mechanism and cellular response to different sizes of
UHMWPE wear particles.Acknowledgements
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Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Fig. 11, are difﬁcult to
interpret in black and white. The full colour images can be found in
the on-line version, at http://dx.doi.org/10.1016/j.actbio.2015.05.
016.
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